首页> Archives of gerontology and geriatrics> The impact of frailty on initiation, continuation and discontinuation of secondary prevention medications following myocardial infarction.

The impact of frailty on initiation, continuation and discontinuation of secondary prevention medications following myocardial infarction.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hannah,Doody

第一单位： Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia; Pharmacy Department, Launceston General Hospital, Tasmania, Australia; Pharmacy Department, Monash Health - Victorian Heart Hospital, Melbourne, Australia.

作者： Hannah,Doody ^[1] ; Justine,Ayre ^[2] ; Adam,Livori ^[3] ; Jenni,Ilomäki ^[4] ; Viviane,Khalil ^[5] ; J Simon,Bell ^[4] ; Jedidiah I,Morton ^[6]

作者单位： Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia; Pharmacy Department, Launceston General Hospital, Tasmania, Australia; Pharmacy Department, Monash Health - Victorian Heart Hospital, Melbourne, Australia. ^[1] Pharmacy Department, Launceston General Hospital, Tasmania, Australia. ^[2] Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia; Grampians Health, Ballarat, Australia. ^[3] Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia. ^[4] Pharmacy Department, Monash Health - Victorian Heart Hospital, Melbourne, Australia; Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne Australia. ^[5] Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia; Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia. Electronic address: jedidiah.morton@monash.edu. ^[6]

关键词 Cardiovascular disease Frailty Myocardial infarction Secondary prevention